Figure 5
From: Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer
Survival curve of the three groups divided by Ep-CAM staining for stages III+IV patients only. Survival of patients by stage divided in those with less than 25% tumour cells staining for CD44v6 (VFF18) compared to those with more than 25% of the tumour cells staining, showing that the prognostic impact is independent of stage.
